SCHEMBL4115544

SCHEMBL4115544

Cc1noc(C(Cc2c[nH]c3ccccc23)NC(=O)OC(C)(C)C)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 4/20 0.64
GAA P10253 3/20 0.64
MAPT P10636 3/20 0.64
POLB P06746 1/20 0.64
NPSR1 Q6W5P4 1/20 0.61
TSHR P16473 1/20 0.60
SSTR3 P32745 1/20 0.59
CTSL P07711 2/20 0.54
CTSS P25774 1/20 0.54
CTSK P43235 1/20 0.54
TACR1 P25103 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
TP53 P04637 1/20 0.51
ACE P12821 1/20 0.49
KLK7 P49862 1/20 0.48
CYP3A4 P08684 1/20 0.47
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789170 0.87 SRC (0.50) P4HBGAAMAPTPOLBTSHR
SCHEMBL28547838 0.87 SRC (0.61) P4HBGAAMAPTPOLBNPSR1
SCHEMBL26611316 0.87 SRC (0.61) P4HBGAAMAPTPOLBNPSR1
SCHEMBL30241815 0.87 SRC (0.61) P4HBGAAMAPTPOLBNPSR1
SCHEMBL19961264 0.84 P4HB (0.57) P4HBGAAMAPTPOLBNPSR1
SCHEMBL29194011 0.84 P4HB (0.76) P4HBGAAMAPTPOLBNPSR1
SCHEMBL30466655 0.84 P4HB (0.76) P4HBGAAMAPTPOLBNPSR1
SCHEMBL30241818 0.84 SRC (0.60) P4HBGAAMAPTPOLBNPSR1
SCHEMBL28546615 0.84 SRC (0.60) P4HBGAAMAPTPOLBNPSR1
SCHEMBL26611805 0.84 SRC (0.60) P4HBGAAMAPTPOLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357705-B2 Substituted cyclohexyldiamines GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
US-20090247591-A1 SUBSTITUTED CYCLOHEXYLDIAMINES GRUNENTHAL GMBH (DE) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247591-A1 SUBSTITUTED CYCLOHEXYLDIAMINES OPRL1, OPRD1, OPRK1 P4HB 4153/4885GAA 4064/4885MAPT 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.